Wellington Management Group LLP Biotechnology

Wellington Management Group LLP

$529 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
HRTX Heron Therapeutics, Inc.	$147M	$1.02 Million 0.0% of portfolio	493,083	Q2 2025 Added 1.2%
GLUE Monte Rosa Therapeutics, Inc.	$324M	$1.01 Million 0.0% of portfolio	224,818	Q2 2025 Added 19.76%
MLTX Moon Lake Immunotherapeutics	$1.97B	$1.01 Million 0.0% of portfolio	21,390	Q2 2025 Reduced 33.5%
CPRX Catalyst Pharmaceuticals, Inc.	$2.03B	$1.01 Million 0.0% of portfolio	46,359	Q2 2025 Reduced 4.31%
ABEO Abeona Therapeutics Inc.	$33.3M	$991,000 0.0% of portfolio	174,514	Q2 2025 Added 13.97%
TYRA Tyra Biosciences, Inc.	$517M	$986,000 0.0% of portfolio	103,078	Q2 2025 Reduced 0.97%
ALT Altimmune, Inc.	$176M	$974,000 0.0% of portfolio	251,866	Q2 2025 Added 11.96%
ABSI Absci Corp	$243M	$972,000 0.0% of portfolio	378,261	Q2 2025 Added 17.07%
OLMA Olema Pharmaceuticals, Inc.	$327M	$971,000 0.0% of portfolio	228,021	Q2 2025 Reduced 84.53%
TRVI Trevi Therapeutics, Inc.	$475M	$940,000 0.0% of portfolio	171,982	Q2 2025 Added 34.94%
CMPX Compass Therapeutics, Inc.	$372M	$904,000 0.0% of portfolio	348,040	Q2 2025 Added 56.42%
FULC Fulcrum Therapeutics, Inc.	$368M	$869,000 0.0% of portfolio	126,402	Q2 2025 New
SMMT Summit Therapeutics Inc.	$3.7B	$844,000 0.0% of portfolio	39,694	Q2 2025 Reduced 1.97%
LGND Ligand Pharmaceuticals Inc	$2.79B	$837,000 0.0% of portfolio	7,370	Q2 2025 Reduced 2.54%
BCRX Biocryst Pharmaceuticals Inc	$1.43B	$777,000 0.0% of portfolio	86,778	Q2 2025 Reduced 5.0%
ARWR Arrowhead Pharmaceuticals, Inc.	$3.08B	$762,000 0.0% of portfolio	48,285	Q2 2025 Reduced 8.23%
IDYA Ideaya Biosciences, Inc.	$1.18B	$753,000 0.0% of portfolio	35,835	Q2 2025 Reduced 1.78%
KMPH Kempharm, Inc	$170M	$722,000 0.0% of portfolio	146,284	Q2 2025 Added 4.18%
IMVT Immunovant, Inc.	$3.55B	$657,000 0.0% of portfolio	23,889	Q2 2025 Reduced 4.56%
PRTA Prothena Corp Public LTD CO	$378M	$654,000 0.0% of portfolio	107,839	Q2 2025 Reduced 97.93%
BEAM Beam Therapeutics Inc.	$1.58B	$633,000 0.0% of portfolio	37,267	Q2 2025 Added 10.81%
ARQT Arcutis Biotherapeutics, Inc.	$1.02B	$620,000 0.0% of portfolio	44,267	Q2 2025 Reduced 5.09%
FHTX Foghorn Therapeutics Inc.	$208M	$556,000 0.0% of portfolio	118,342	Q2 2025 Added 15.02%
TVTX Travere Therapeutics, Inc.	$1.52B	$518,000 0.0% of portfolio	35,009	Q2 2025 Added 5.54%
HRMY Harmony Biosciences Holdings, Inc.	$1.9B	$497,000 0.0% of portfolio	15,732	Q2 2025 Reduced 3.82%
OMER Omeros Corp	$257M	$490,000 0.0% of portfolio	163,413	Q2 2025 Added 20.15%
RXRX Recursion Pharmaceuticals, Inc.	$850M	$480,000 0.0% of portfolio	94,982	Q2 2025 Reduced 11.62%
AUPH Aurinia Pharmaceuticals Inc.	$1.75B	$467,000 0.0% of portfolio	55,217	Q2 2025 Added 0.05%
LXRX Lexicon Pharmaceuticals, Inc.	$211M	$462,000 0.0% of portfolio	486,674	Q2 2025 New
INVA Innoviva, Inc.	$1.36B	$459,000 0.0% of portfolio	22,862	Q2 2025 Reduced 6.29%
CADL Candel Therapeutics, Inc.	$142M	$436,000 0.0% of portfolio	86,247	Q2 2025 New
VERA Vera Therapeutics, Inc.	$656M	$436,000 0.0% of portfolio	18,512	Q2 2025 Reduced 2.88%
ETON Eton Pharmaceuticals, Inc.	$451M	$416,000 0.0% of portfolio	29,213	Q2 2025 Added 15.54%
THRD Third Harmonic Bio, Inc.	$217M	$410,000 0.0% of portfolio	75,658	Q2 2025 New
CRVS Corvus Pharmaceuticals, Inc.	$271M	$409,000 0.0% of portfolio	102,347	Q2 2025 Reduced 2.41%
LIFE A Tyr Pharma Inc	$53.2M	$399,000 0.0% of portfolio	214,928	Q2 2025 Added 27.37%
NVAX Novavax Inc	$656M	$399,000 0.0% of portfolio	63,432	Q2 2025 Reduced 2.85%
ARDX Ardelyx, Inc.	$1B	$382,000 0.0% of portfolio	97,599	Q2 2025 Reduced 4.29%
GERN Geron Corp	$480M	$351,000 0.0% of portfolio	249,489	Q2 2025 Reduced 91.64%
KOD Kodiak Sciences Inc.	$487M	$345,000 0.0% of portfolio	92,505	Q2 2025 New
DYN Dyne Therapeutics, Inc.	$666M	$323,000 0.0% of portfolio	34,018	Q2 2025 Reduced 6.34%
SNDX Syndax Pharmaceuticals Inc	$896M	$319,000 0.0% of portfolio	34,085	Q2 2025 Reduced 5.22%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	1,433,187	Q2 2025 Added 987.59%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.